We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

False-Positive Dopamine in Pheochromocytoma Treated With Tyrosine Derivative

P. A. Serrano; B. Chávez Lara
JAMA. 1973;223(1):80. doi:10.1001/jama.1973.03220010066029.
Text Size: A A A
Published online


To the Editor.—  Alpha-methyl-p-tyrosine is a drug under experimental use for the the treatment of pheochromocytoma, which also blocks the biosynthesis of catecholamine, inhibiting the tyrosine hydroxylase. Usually it gave a satisfactory control of arterial hypertension, together with a clear decrease in the excretion of norepinephrine and 4-hydroxy-3-methoxymandelic acid (vanillylmandelic acid [VMA]). Recently, we had the opportunity to study four patients with nonmalignant pheocromocytoma; three of them were excreting dopamine in higher levels than the normal rate during the control period. The tumors were localized; three extra-adrenally and one on the adrenal gland. After administration of alpha-methyl-p-tyrosine (500 to 2,000 mg/day), blood pressure was satisfactorily controlled and the excretion of norepinephrine and VMA markedly decreased. The dopamine, which was in levels above 1,000μg/24 hr increased in the patients with high dopamine excretion and reached values up to 8,000μg/24 hr in one of the patients after five


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.